Skip to main content
. 2023 Jul 3;15(13):3474. doi: 10.3390/cancers15133474

Table 3.

Novel prognostic biomarkers for NSCLC.

Biomarker Outcome
TP53 Resistance to Therapy increased.
VEGF Poor prognosis, metastasis, tumor recurrence.
TUBB3 Poor prognosis
KIAA1522 Poor prognosis and lower response rate
nm23-H1 Low levels poor prognosis
TGF-β Poor prognosis
LAG-3 Better survival
NLR&PLR Worse overall survival
Ki-67 Poor prognosis